Cargando…
Umifenovir Epigenetically Targets the IL-10 Pathway in Therapy against Coxsackievirus B4 Infection
Umifenovir, a broad-spectrum nonnucleoside antiviral drug, has a promising efficacy against coxsackievirus B4 (CVB4) infection, but its mechanism remains unclear. CVB4 is a common human single-stranded RNA virus that belongs to the Picornaviridae family and the Enterovirus genus. Enterovirus can cau...
Autores principales: | Zhang, Shilin, Xue, Xiao, Qiao, Sennan, Jia, Lin, Wen, Xue, Wang, Yichen, Wang, Cong, Li, Hongrui, Cui, Jiuwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927110/ https://www.ncbi.nlm.nih.gov/pubmed/36541788 http://dx.doi.org/10.1128/spectrum.04248-22 |
Ejemplares similares
-
Antioxidant Potential of Antiviral Drug Umifenovir
por: Proskurnina, Elena V., et al.
Publicado: (2020) -
Moxifloxacin/umifenovir: Pancytopenia and off label use: case report
Publicado: (2021) -
Reinforcing the supply chain of umifenovir and other antiviral drugs with retrosynthetic software
por: Lin, Yingfu, et al.
Publicado: (2021) -
Molecular mechanism of antibody neutralization of coxsackievirus A16
por: Zhang, Chao, et al.
Publicado: (2022) -
Effect of Arbidol (Umifenovir) on COVID-19: a randomized controlled trial
por: Nojomi, Marzieh, et al.
Publicado: (2020)